Cleared Traditional

ControlRad Trace Model 9 (K200663) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K200663 · Controlrad, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
103d
Days
Class 2
Risk

K200663 is an FDA 510(k) clearance for the ControlRad Trace Model 9. Classified as Interventional Fluoroscopic X-ray System (product code OWB), Class II - Special Controls.

Submitted by Controlrad, Inc. (Norcross, US). The FDA issued a Cleared decision on June 24, 2020 after a review of 103 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Controlrad, Inc. devices

Submission Details

510(k) Number K200663 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 13, 2020
Decision Date June 24, 2020
Days to Decision 103 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 107d · This submission: 103d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OWB Interventional Fluoroscopic X-ray System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Secure BioMed Evaluations
Linda Braddon

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OWB Interventional Fluoroscopic X-ray System

All 185
Devices cleared under the same product code (OWB) and FDA review panel - the closest regulatory comparables to K200663.
Ziehm Vision RFD 3D
K202360 · Ziehm Imaging GmbH · Sep 2020
Digiscan FDX
K200218 · Allengers Medical Systems Limited · Jul 2020
ARTIS pheno (VE2)
K201156 · Siemens Medical Solution USA, Inc. · Jun 2020
CFP-3131, CFP-2222
K201172 · Mx Imaging, Inc. · May 2020
Azurion R2.1
K200917 · Philips Medical Systems Nederland B.V. · May 2020
O-arm O2 Imaging System
K200074 · Medtronic, Inc. · Apr 2020